News
At the recent SEC meeting for endocrinology and metabolism, the expert panel reviewed the proposal along with the ...
The changes will impact millions of people with type 2 diabetes in England in the biggest shake-up of care in a decade ...
A new study published in the European Journal of Medical Research revealed that dapagliflozin, a sodium-glucose ...
7d
TipRanks on MSNAstraZeneca’s Latest Study on Balcinrenone/Dapagliflozin: Key Insights for Investors
The study tested the effects of balcinrenone/dapagliflozin, a combination drug, in different conditions: fasted, fed, and with the P-gp inhibitor quinidine. The goal was to understand how these ...
5d
TipRanks on MSNAstraZeneca’s Phase I Study on Balcinrenone/Dapagliflozin: Key Insights for Investors
The study tested the effects of balcinrenone/dapagliflozin, a drug combination, both in fed and fasted states, and with the addition of quinidine, a P-gp inhibitor. The purpose is to understand how ...
3h
inews.co.uk on MSNNHS diabetes shake-up could save 22,000 lives with earlier access to weight-loss jabs
The NHS should move away from a one-size-fits-all approach of starting everyone on the same medication, to more personalised care that aims to prevent complications like heart failure and heart ...
Cookies are files saved on your phone, tablet or computer when you visit a website. We use cookies to store information about how you use the NICE website and services, such as the pages you visit.
AstraZeneca PLC thrives with $54B revenue and 14 blockbusters in 2024, fueled by oncology and rare disease growth. Click for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results